Merrimack is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer. Merrimack’s mission is to provide patients, physicians and the healthcare system with the medicines, tools and information on the diagnosis and treatment of illness through a more precise mechanistic understanding of disease. Merrimack seeks to accomplish this mission by applying its proprietary systems biology-based approach to biomedical research, which Merrimack calls Network Biology.

Latest News